Cargando…
Cytidine deaminase activity increases in the blood of breast cancer patients
Cytidine deaminase (CDA), an enzyme of the pyrimidine salvage pathway, deaminates cytidine, deoxycytidine and analogs, such as gemcitabine. Constitutive low levels of CDA activity have been reported in the blood of patients with hematological malignancies or suffering from gemcitabine toxicity. We p...
Autores principales: | Buhagiar-Labarchède, Géraldine, Onclercq-Delic, Rosine, Vacher, Sophie, Berger, Frédérique, Bièche, Ivan, Stoppa-Lyonnet, Dominique, Amor-Guéret, Mounira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388666/ https://www.ncbi.nlm.nih.gov/pubmed/35982128 http://dx.doi.org/10.1038/s41598-022-18462-8 |
Ejemplares similares
-
Author Correction: Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar‑Labarchède, Géraldine, et al.
Publicado: (2022) -
Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels
por: Mameri, Hamza, et al.
Publicado: (2022) -
Pyrimidine Pool Disequilibrium Induced by a Cytidine Deaminase Deficiency Inhibits PARP-1 Activity, Leading to the Under Replication of DNA
por: Gemble, Simon, et al.
Publicado: (2015) -
A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival
por: Bou Samra, Elias, et al.
Publicado: (2017) -
A decrease in NAMPT activity impairs basal PARP-1 activity in cytidine deaminase deficient-cells, independently of NAD(+)
por: Silveira, Sandra Cunha, et al.
Publicado: (2020)